Increased sensitivity of striatal dopamine release to H2O 2 upon chronic rotenone treatment

Free Radical Biology and Medicine

Volumn 39, Issue 1, 2005, Pages 133-142

  Milusheva, Elisaveta ^a,b   Baranyi, Mária ^a   Kittel, Ágnes ^a   Sperlágh, Beáta ^a   Vizi, E Sylvester ^a  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b INSTITUTE OF PHYSIOLOGY   (Bulgaria)

Author keywords

Acetylcholine; Dopamine; H 2O2; Oxidative stress; Parkinson's disease; Release; Striatum

Indexed keywords

ACETYLCHOLINE; DOPAMINE; DOPAMINE 2 RECEPTOR; HYDROGEN PEROXIDE; QUINONE DERIVATIVE; ROTENONE; TYROSINE 3 MONOOXYGENASE;

ARTICLE; CELL SURVIVAL; CONTROLLED STUDY; DOPAMINE RELEASE; DOPAMINERGIC SYSTEM; DRUG EFFECT; ELECTROSTIMULATION; IMMUNE RESPONSE; IMMUNOREACTIVITY; MALE; MITOCHONDRION; NERVE CELL; NERVE CELL DIFFERENTIATION; NEUROTRANSMISSION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT; STRIATE CORTEX;

ACETYLCHOLINE; ANIMALS; CORPUS STRIATUM; DOPAMINE; HYDROGEN PEROXIDE; MALE; OXIDATIVE STRESS; PARKINSONIAN DISORDERS; RATS; RATS, SPRAGUE-DAWLEY; ROTENONE; SULPIRIDE; TYROSINE 3-MONOOXYGENASE;

EID: 19544371066     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2005.02.034     Document Type: Article

References (32)

1. H. Ischiropoulos, and J.S. Beckman Oxidative stress and nitration in neurodegeneration: cause, effect, or association? J. Clin. Invest. 111 2003 163 169
2. B. Halliwell Reactive oxygen species and the central nervous system J. Neurochem. 59 1992 1609 1623
3. J.L. Cadet, and C. Brannock Free radicals and the pathobiology of brain dopamine systems Neurochem. Int. 32 1998 117 131
4. 3H]noradrenaline in response to oxidative stress combined with mitochondrial dysfunction in rat hippocampal slices Neuroscience 120 2003 771 781
5. B.A. McLaughlin, D. Nelson, M. Erecinska, and M.F. Chesselet Toxicity of dopamine to striatal neurons in vitro and potentiation of cell death by a mitochondrial inhibitor J. Neurochem. 70 1998 2406 2415
6. J.M. Gorell, C.C. Johnson, B.A. Rybicki, E.I. Peterson, and R.J. Richardson The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living Neurology 50 1998 1346 1350
7. A. Menegon, P.G. Board, A.C. Blackburn, G.D. Mellick, and D.G. Le Couteur Parkinson's disease, pesticides, and glutathione transferase polymorphisms Lancet 352 1998 1344 1346
8. A.H. Schapira, J.M. Cooper, D. Dexter, P. Jenner, J.B. Clark, and C.D. Marsden Mitochondrial complex I deficiency in Parkinson's disease Lancet 1 1989 1269
9. R. Betarbet, T.B. Sherer, G. MacKenzie, M. Garcia-Osuna, A.V. Panov, and J.T. Greenamyre Chronic systemic pesticide exposure reproduces features of Parkinson's disease Nat. Neurosci. 3 2000 1301 1306
10. E.C. Hirsch, G. Hoglinger, E. Rousselet, T. Breidert, K. Parain, J. Feger, M. Ruberg, A. Prigent, C. Cohen-Salmon, and J.M. Launay Animal models of Parkinson's disease in rodents induced by toxins: an update J. Neural. Transm. Suppl. 65 2003 89 100
11. C. Thiffault, J.W. Langston, and D.A. Di Monte Increased striatal dopamine turnover following acute administration of rotenone to mice Brain Res. 885 2000 283 288
12. M. Alam, and W.J. Schmidt Rotenone destroys dopaminergic neurons and induces parkinsonian symptoms in rats Behav. Brain Res. 136 2002 317 324
13. M. Alam, and W.J. Schmidt L-DOPA reverses the hypokinetic behaviour and rigidity in rotenone treated rats Behav. Brain Res. 153 2004 439 446
14. C.H. Langeveld, E. Schepens, J.C. Stoof, A. Bast, and B. Drukarch Differential sensitivity to hydrogen peroxide of dopaminergic and noradrenergic neurotransmission in rat brain slices Free Radic. Biol. Med. 19 1995 209 217
15. H.S. Maker, C. Weiss, and T.S. Brannan Amine-mediated toxicity. The effects of dopamine, norepinephrine, 5-hydroxytryptamine, 6-hydroxydopamine, ascorbate, glutathione and peroxide on the in vitro activities of creatine and adenylate kinases in the brain of the rat Neuropharmacology 25 1986 25 32
16. J. Segura-Aguilar, D. Metodiewa, and C.J. Welch Metabolic activation of dopamine o-quinones to o-semiquinones by NADPH cytochrome P450 reductase may play an important role in oxidative stress and apoptotic effects Biochim. Biophys. Acta 1381 1998 1 6
17. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement wiht the folin phenol reagent J. Biol. Chem. 193 1951 265 275
18. A.J. Nappi, and E. Vass The effect of nitric oxide on the oxidations of l-Dopa and dopamine mediated by tyrosinase and peroxidase J. Biol. Chem. 276 2001 11214 11222
19. T.B. Sherer, J.H. Kim, R. Betarbet, and J.T. Greenamyre Subcutaneous rotenone exposure causes highly selective dopaminergic degeneration and alpha-synuclein aggregation Exp. Neurol. 179 2003 9 16
20. T. Sherer, B.R. Betarbet, C.M. Testa, B.B. Seo, J.R. Richardson, J.H. Kim, G.W. Miller, T. Yagi, A. Matsuno-Yagi, and J.T. Greenamyre Mechanism of toxicity in rotenone models of Parkinson's disease J. Neurosci. 23 2003 10756 10764
21. T.B. Sherer, R. Betarbet, J.H. Kim, and J.T. Greenamyre Selective microglial activation in the rat rotenone model of Parkinson's disease Neurosci. Lett. 341 2003 87 90
22. G.U. Hoglinger, J. Feger, A. Prigent, P.P. Michel, K. Parain, P. Champy, M. Ruberg, W.H. Oertel, and E.C. Hirsch Chronic systemic complex I inhibition induces a hypokinetic multisystem degeneration in rats J. Neurochem. 84 2003 491 502
23. N. Lapointe, M. St-Hilaire, M.G. Martinoli, J. Blanchet, P. Gould, C. Rouillard, and F. Cicchetti Rotenone induces non-specific central nervous system and systemic toxicity FASEB J. 18 2004 717 719
24. C. Perier, J. Bove, M. Vila, and S. Przedborski The rotenone model of Parkinson's disease Trends Neurosci. 26 2003 345 346
25. Y. He, S.Z. Imam, Z. Dong, J. Jankovic, S.F. Ali, S.H. Appel, and W. Le Role of nitric oxide in rotenone-induced nigro-striatal injury J. Neurochem. 86 2003 1338 1345
26. M.J. LaVoie, and T.G. Hastings Peroxynitrite- and nitrite-induced oxidation of dopamine: implications for nitric oxide in dopaminergic cell loss J. Neurochem. 73 1999 2546 2554
27. N. Sakka, H. Sawada, Y. Izumi, T. Kume, H. Katsuki, S. Kaneko, S. Shimohama, and A. Akaike Dopamine is involved in selectivity of dopaminergic neuronal death by rotenone Neuroreport 14 2003 2425 2428
28. H. Bernheimer, W. Birkmayer, O. Hornykiewicz, K. Jellinger, and F. Seitelberger Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations J. Neurol. Sci. 20 1973 415 455
29. P. Riederer, and S. Wuketich Time course of nigrostriatal degeneration in Parkinson's disease. A detailed study of influential factors in human brain amine analysis J. Neural Transm. 38 1976 277 301
30. L. Tretter, I. Sipos, and V. Adam-Vizi Initiation of neuronal damage by complex I deficiency and oxidative stress in Parkinson's disease Neurochem. Res. 29 2004 569 577
31. I. Sipos, L. Tretter, and V. Adam-Vizi The production of reactive oxygen species in intact isolated nerve terminals is independent of the mitochondrial membrane potential Neurochem. Res. 28 2004 1575 1581
32. H.M. Gao, J.S. Hong, W. Zhang, and B. Liu Distinct role for microglia in rotenone-induced degeneration of dopaminergic neurons J. Neurosci. 22 2002 782 783